医学と薬学　73/3　2016年3月号

出版社： 自然科学社
発行日： 2016-02-27
分野： 薬学  >  雑誌
ISSN： 03893898
雑誌名：
特集： 内科医も知っておきたい子どもの感染症（II）―たかが風邪、されど風邪
電子書籍版： 2016-02-27 （第1版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

2,200 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

1,100 円(税込)

購入する

目次

  • 医学と薬学　73/3　2016年3月号

    ―目次―

    特集　内科医も知っておきたい子どもの感染症（II）
    ―たかが風邪、されど風邪

    ●油断できない合併症
    インフルエンザ脳症
    エンテロウイルス性心筋炎
    ロタウイルス感染による中枢神経合併症

    ●油断できない子どもたち
    RSウイルス感染症
    乳児期早期の発熱

    臨床報告
    難治性の疼痛に対する抑肝散加陳皮半夏の有用性の検討

    Diagnosis
    全自動化学発光免疫測定装置ARCHITECT
    　　アナライザー用測定試薬PIVKA-II の基礎的検討
    　ヒトメタニューモウイルス（hMPV）
    　　抗原迅速診断キット“イムノエース(R) hMPV”
    　　の有用性に関する検討
    　EIA 法による血漿レニン活性測定キットである
    　　レニン活性キット「ヤマサ」の開発とその基礎的検討　
    　電気化学発光免疫測定法（ECLIA 法）を用いた
    　　プロゲステロン測定キット
    　　「エクルーシス試薬プロゲステロンIII」の基本性能評価
    　　および基準範囲の検討　
    　ラテックス免疫比濁法を用いた
    　　新しい血清Helicobacter pylori 抗体検出キットの診断精度

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

【特集 内科医も知っておきたい子どもの感染症 ( II ) - たかが風邪, されど風邪】

P.255 掲載の参考文献
1) 河島尚志, 柏木保代, 芹沢博美他 : インフルエンザ流行中の急死例における肝病理所見. 小児感染免疫 12 : 185-190, 2000.
 
2) 森島恒雄, 富樫武弘, 横田俊平他 : インフルエンザに合併する脳炎・脳症に関する全国調査. 日本医事新報 3953 : 26-28, 2001.
 
3) 吉村元, 今井幸弘, 別府美奈子他 : 高齢者インフルエンザ脳症の1剖検例. 臨床神経 48 : 713-720, 2008.
 
4) Gu Y, Shimada T, Yasui Y et al : National surveillance of influenza-associated encephalopathy in Japan over six years, before and during the 2009-2010 influenza pandemic. PLoS One 8 (1) : e54786, 2013.
PubMed
5) Mori SI, Nagashima M, Sasaki Y et al : A novel amino acid substitution at the receptor-binding site on the hemagglutinin of H3N2 influenza A viruses isolated from 6 cases with acute encephalopathy during the 1997-1998 season in Tokyo. Arch Virol 144 (1) : 147-155, 1999.
 
6) 森島恒雄 : 小児の急性脳炎・脳症の現状. ウイルス 59 : 59-66, 2000.
 
7) Morishima T, Togashi T, Yokota S. et al Encephalitis and encephalopathy associated with influenza epidemic in Japan. Clin Inf Dis 35 : 512-517, 2002.
 
8) 森島恒雄 : インフルエンザの臨床経過中に発生する脳炎・脳症の疫学及び病態に関する研究 (H12-新興-11), 平成12年研究成果報告書, pp. 1-135, 2001.
 
9) Mizuguchi M, Yamanouchi H , Ichiyama T et al : Acute encephalopathy associated with influenza and other viral infections. Acta Neurol Scand 115 (Suppl 186) : 45-56, 2007.
 
10) 塩見正司 : インフルエンザ脳症の臨床スペクトラム. 小児内科 35 : 1676-1681, 2003.
 
11) 塩見正司 : インフルエンザ脳症. 小児科臨床 53 : 1739-1746, 2000.
Medical*Online
12) Kawashima H, Morichi S, Okumara A et al : National survey of pandemic influenza A (H1N1) 2009-associated encephalopathy in Japanese children. J Med Virol 84 (8) : 1151-1156, 2012.
 
13) 森島恒雄 : インフルエンザの臨床経過中に発生する脳炎・脳症の疫学及び病態に関する研究 (H12-新興-11), 平成13年研究成果報告書, pp. 1-84, 2002.
 
14) 富樫武弘, 松薗嘉裕, 板倉治他 : インフルエンザ流行中にみられる小児期脳炎・脳症患者の脳脊髄液中IL-6, TNF-α. 日小児会誌 103 : 16-19, 1999.
 
15) Ichiyama T, Isumi H, Ozawa H et al : Cerebrospinal fluid and serum levels of cytokines and soluble tumor necrosis factor receptor in influenza virus-associated encephalopathy. Scand J Infect Dis 35 (1) : 59-61, 2003.
PubMed
16) 布井博幸, 水上智之, レジナ・マルカド他 : インフルエンザ感染症における重症度判定のためのマーカーの検討. 小児感染免疫 13 : 225-232, 2001.
 
17) Kawashima H, Watanabe Y, Ichiyama T et al : High concentration of serum NOx (nitrite/nitrate) obtained from patients with influenza-associated encephalopathy. Pediatr Internat 44 (6) : 705-707, 2002.
 
18) Kawashima H, Watanabe Y, Morishima T et al : NOx (nitrite /nitrate) in cerebral spinal fluids obtained from patients with influenza-associated encephalopathy. Neuropediatrics 34 (3) : 137-140, 2003.
PubMed
19) Kawashima H, Oguchi M, Ioi H et al : Primary biomarkers in cerebral spinal fluid obtained from patients with influenza-associated encephalopathy analyzed by metabolomics. Int J Neurosci 116 (8) : 927-936, 2006.
PubMed
20) Ichiyama T, Morishima T, Kajimoto M et al : Matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 in influenza-associated encephalopathy. Pediatr Infect Dis J 26 (6) : 542-544, 2007.
PubMed
21) Tsuge M, Yasui K, Ichiyawa T et al : Increase of tumor necrosis factor-alpha in the blood induces early activation of matrix metalloproteinase-9 in the brain. Microbiol Immunol 54 (7) : 417-424, 2010.
PubMed
22) Morichi S, Yamanaka G, Ishida Y et al : Brain-derived neurotrophic factor and interleukin-6 levels in the serum and cerebrospinal fluid of children with viral infection-induced encephalopathy. Neurochem Res 39 (11) : 2143-2149, 2014.
PubMed
23) 眞木崇州, 猪原匡史 : Neurovascular unitの概念から導きだされる中枢新駅疾患の治療戦略. 実験医学 31 (4) : 2230-2235, 2013.
 
24) Momonaka H, Hasegawa S, Matsushige T et al : High mobility group box 1 in patients with 2009 pandemic H1N1 influenza-associated encephalopathy. Brain Dev 36 (6) : 484-488, 2014.
PubMed
25) 山口清次 : インフルエンザ脳症の発症因子の解明と治療及び予防方法の確立に関する研究, 平成15年度厚生科学研究費補助金研究報告書, pp. 76-77, 2004.
 
26) Shinohara M, Saitoh M, Takanashi J et al : Carnitine palmitoyl transferase II polymorphism is associated with multiple syndromes of acute encephalopathy with various infectious diseases. Brain Dev 33 (6) : 512-517, 2011.
PubMed
27) Chen Y, Mizuguchi H, Yao D et al : Thermolabile phenotype of carnitine palmitoyltransferase II variations as a predisposing factor forinfluenza-associated encephalopathy. FEBS Lett 79 (10) : 2040-2044, 2005.
 
28) Shinohara M, Saitoh M, Nishizawa D et al : ADORA2A polymorphism predisposes children to encephalopathy with febrile status epilepticus. Neurology 80 (17) : 1571-1576, 2013.
PubMed
29) 厚生労働省インフルエンザ脳症研究班 : インフルエンザ脳症ガイドライン (改訂版), pp. 1-55, 2005.
 
30) Nakazawa M, Akasaka M, Hasegawa T et al : Efficacy and safety of fosphenytoin for acute encephalopathy in children. Brain Dev 37 (4) : 418-422, 2015.
PubMed
P.262 掲載の参考文献
1) Saji T, Matsuura H, Hasegawa K et al : Comparison of the clinical presentation, treatment, and outcome of fulminant and acute myocarditis in children. Circ J 76 : 1222-1228, 2012.
PubMed
2) Kuhl U, Pauschinger M, Noutsias M et al : High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction. Circulation 111 : 887-893, 2005.
PubMed
3) Fujioka S, Kitaura Y, Deguchi H et al : Evidence of viral infection in the myocardium of American and Japanese patients with idiopathic dilated cardiomyopathy. Am J Cardiol 94 : 602-605, 2004.
PubMed
4) Pankuweit S, Moll R, Baandrup U et al : Prevalence of the Parbovirus B19 genome in endomyocardial biopsy specimens. Hum Pathol 34 : 497-503, 2003.
 
5) Nielsen TS, Hansen J, Nielsen LP et al : The presence of enterovirus, adenovirus, and Parbovirus B19 in myocardial tissue samples from autopsies. : an evaluation of their frequencies in deveased indivisuals with myocarditis and in non-inflamed control heart. Forensic Sci Med Pathol 10 : 344-350, 2014.
 
6) Gaaloul I, Riabi S, Harrath R et al : Coxsackievirus B detection in cases of myocarditis, myopericarditis, pericarditis and dilated cardiomyopathy in hospitalized patients. Mol Med Rep 10 : 2811-2818, 2014.
PubMed
7) Cooper LT : Myocarditis. N Engl J Med 360 : 1526-1538, 2009.
PubMed
8) Hilinski JA : Myocarsitis. Principles and Practice of Pediatric Infectious Disease, 3rd ed (ed. by Long SS, Pickering LK, Prober CG), Chapter 40, pp. 278-280, Churchill Livingstone, Philadelphia, 2008.
 
9) Andreoletti L, VenteoL, Douche-Aourik F et al : Active Coxsackieviral B infection is associated with disruption of dystrophin in endomyocardial tissue of patients who died suddenly of acute myocardial infarction. J Am Coll Cardiol 50 : 2207-2214, 2007.
PubMed
10) Kindermann I, kindermann M, kandorf R et al : Predictors of outcome in patients with suspected myocarditis, Circulation 118 : 6639-6648, 2008.
 
11) Barton M, Finkelstein Y, Opavsky M et al : Eosinophilic myocarditis temporally associated with conjugate meningococcal C and hepatitis B vaccines in children. Pediatr Infect Dis J 27 : 831-835, 2008.
 
12) Arness MK, Eckart RE, Love SS et al : Myopericarditis following smallpox vaccination. Am J Epidemiol 160 : 642-651, 2004.
PubMed
13) Dettmeyer R, Baasner A, Schlamann M et al : Role of virus-induced myocardial affections in sudden infant death syndrome : a prospective postmortem study. Pediatr Res 55 : 947-952, 2004.
PubMed
14) Baasner A, Dettmeyer R, Graebe M et al : PCRbased diagnosis of enterovirus and Parbovirus B19 in paraffin-embedded heart tissue of children with suspected sudden infant death syndrome. Lab Invest 83 : 1451-1455, 2003.
 
15) Coyne CB, Bergelson JM : Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions. Cell 124 : 119-131, 2006.
PubMed
16) Martino TA, Petric M, Brown M et al : Cardiovirulent coxsackieviruses and the decay-accelerating factor (CD55) receptor. Virology 244 : 302-314, 1998.
PubMed
17) Bowles NE, Vallejo J : Viral causes of cardiac inflammation. Curr Opin Cardiol 18 : 182-188, 2003.
PubMed
18) Perens G, Levi DS, Alejos JC et al : Muronomab-CD3 for pediatric acute myocarditis. Pediatr Cardiol 28 : 21-26, 2007.
PubMed
19) Gifford R, Dalldorf G : Morbid anatomy of experimental Coxsackie virus infection. Am J Pathol 27 : 1047-1063, 1951.
PubMed
20) Matzinger P : The danger model : a renewed sense of self. Science 296 : 301-305, 2002.
 
21) Fuse K, Chan G, Liu Y et al : Myeloid differentiation factor-88 plays a crucial role in the pathogenesis of Coxsackievirus B3-induced myocarditis and influences type I interferon production. Circulation 112 : 2276-2285, 2005.
 
22) Fairweather D, Frisancho-Kiss S, Rose NR : Viruses as adjuvants for autoimmunity : evidence from Coxsackievirus-induced myocarditis. Rev Med Virol 15 : 17-27, 2005.
PubMed
23) Frisancho-Kiss S, Davis SE, Nyland JF et al : Cutting edge : cross-regulation by TLR4 and T cell Ig mucin-3 determines sex differences in inflammatory heart disease. J Immunol 178 : 6710-6714, 2007.
 
24) Opavsky MA, Penninger J, Aitken K et al : Susceptibility to myocarditis is dependent on the response of alphabeta T lymphocytes to coxsackieviral infection. Circ Res 85 : 551-558, 1999.
PubMed
25) Huber SA, Feldman AM, Sartini D : Coxsackievirus B3 induces T regulatory cells, which inhibit cardiomyopathy in tumor necrosis factor-alpha transgenic mice. Circ Res 99 : 1109-1116, 2006.
PubMed
26) Massilamany C, Gangaplara A, Reddy J : Intricacies of cardiac damage in coxsackievirus B3 infection. Int J Cardiol 177 : 330-339, 2014.
PubMed
27) Fairweather D, Frisancho-Kiss S, Gatewood S et al : Mast cells and innate cytokines are associated with susceptibility to autoimmune heart disease following coxsackievirus B3 infection. Autoimmunity 37 : 131-145, 2004.
PubMed
28) Rangachari M, Mauermann N, Marty RR et al : T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17. J Exp Med 203 : 2009-2019, 2006.
PubMed
29) Leuschner F, Courties G, Dutta P et al : Silencing of CCR2 in myocarditis. Eur Heart J 36 : 1478-1488, 2015.
PubMed
30) Li Y, Heuser JS, Cunningham LC et al : Mimicry and antibody-mediated cell signaling in autoimmune myocarditis. J Immunol 177 : 8234-8240, 2006.
PubMed
31) Antone SM, Adderson EE, Mertens NM et al : Molecular analysis of V gene sequences encoding cytotoxic anti-streptococcal/anti-myosin monoclonal antibody 36. 2. 2 that recognizes the heart cell surface protein laminin. J Immunol 159 : 5422-5430, 1997.
PubMed
32) Galvin JE, Hemric ME, Ward K et al : Cytotoxic mAb from rheumatic carditis recognizes heart valves and laminin. J Clin Invest 106 : 217-224, 2000.
PubMed
33) Li Y, Heuser JS, Cunningham LC et al : Mimicry and antibody-mediated cell signaling in autoimmune myocarditis. J Immunol 177 : 8234-8240, 2006.
PubMed
34) Li Y, Bourlet T, Andreoletti L et al : Enteroviral capsid protein VP1 is present in myocardial tissues from some patients with myocarditis or dilated cardiomyopathy. Circulation 101 : 231-234, 2000.
 
35) Schultheiss H-P, Kuhl U, Cooper LT : The management of myocarditis. Eur Heart J 32 : 2616-2625, 2011.
PubMed
36) Wu J, Shen L, Chen J et al : The role of microRNAs in enteroviriral infections. Braz J Infect Dis 19 : 510-516, 2015.
 
37) Saji T, Matsuura H, Hasegawa K et al : Comparison of the clinical presentation, treatment, and outcome of fulminant and acute myocarditis in children. Circulation J 76 : 1222-1228, 2012.
 
38) 佐地勉, 瀬川昌已, 蜂谷正彦他 : FISH法により弁組織にエンテロウイルスgenomeを証明えた腱索断裂による僧帽弁閉鎖不全を伴う急性心筋炎の1例. 呼吸と循環 43 : 87-91, 1995.
 
39) Shiraishi I, Nishimura K, Sakaguchi H et al : Acuute rupture of chordae tendineae of the mitral valve in infants : a nationwide survey in Japan exploring a new syndrome. Circulation 130 : 1053-61, 2014.
 
40) 佐地勉 : 心筋炎の劇症化因子に関するコメント. 心臓 35 : 629-631, 2003.
 
41) Lucke B, Wight T, Kime E : Pathologic anatomy and bacteriology of influenza : epidemics of autumn 1918. Arch Intern Med 24 : 154-237, 1919.
 
42) 佐地勉, 松尾準雄 : ウイルス性心筋炎の臨床. 小児科 30 : 1031-1043, 1989.
 
43) Remington JS, Klein JO, eds : Infectious disease of the fetus and new born infant, 2nd ed, pp. 290-334, WB Saunders, Philadelphia, 1983.
 
44) Akhtar N, Ni J, Stromberg D et al : Tracheal aspirate as a substrate for polymerase chain reaction detection of viral genome in childhood pneumonia and myocarditis. Circulation 99 (15) : 2011-2018, 1999.
PubMed
45) Abzung MJ : Perinatal enterovirus infection. In Human Enterovirus infections ed by Rotbart HA, pp. 221-238, ASM Press, Washington DC, 1995.
 
46) 佐地勉 : 心筋炎. 高尾篤良, 門間和夫, 中澤誠他編, 臨床発達心臓病学, 初版, pp. 608-619, 中外医学社, 東京, 1989.
 
47) EisenhutM, Algawi B, Wreghitt T et al : Fatal Coxsackie A9 virus infection during a outbreak in a neonatal unit. J Infection 40 : 297-298, 2000.
 
48) 佐地勉, 中澤誠, 原田研介 他 : 新生児期急性心筋炎の診断と治療-全国調査成績-. 日小循会誌 20 : 12-15, 2004.
 
49) Magnani JW, Dec GW : Myocarditis : current trends in diagnosis and treatment. Circulation 113 : 876-890, 2006.
PubMed
50) Friedich MG, Sechterm U, Schulz-Menger J et al : Cardiovascular magnetic resonance in myocarditis : A JACC white paper. J Amer Coll Cardiol 53 : 1475-1478, 2009.
 
51) 佐地勉 : 心筋炎. 高尾篤良, 門間和夫, 中澤誠他編 : 臨床発達心臓病学, 第3版, pp. 684-699, 中外医学社, 東京, 2001.
 
52) 和泉徹, 磯部光章, 河合祥雄他 : 急性および慢性心筋炎の診断・治療に関するガイドライン, 2009年改訂版. 日本循環器学会ガイドライン, http://www.j-circ.or.jp/guideline/pdf/JCS2009_izumi_h.pdf
 
53) Sachdeva S, Song X, Dham N et al : Analysis of clinical parameters and cardiac magnetic resonance imaging as predictors of outcome in pediatric myocarditis. Am J Cardiol 115 : 499-504, 2015.
PubMed
54) Magnani JW, Dec GW : Myocarditis : current trends in diagnosis and treatment. Circulation 113 : 876-890, 2006.
PubMed
55) Matsumori A, Igata H, Ono K et al : High doses of digitalis increase the myocardial production of proinflammatory cytokines and worsen myocardial injury in viral myocarditis : a possible mechanism of digitalis toxicity. Jpn Circ J 63 : 934-940, 1999.
PubMed
56) Lenzo JC, Shellam GR, Lawson CM : Ganciclovir and cidofovir treatment of cytomegalovirus-induced myocarditis in mice. Antimicrob Agents Chemother 45 : 1444-1449, 2001.
PubMed
57) Abzug MJ, Michaels MG, Wald E et al : A randomized, double-blind, placebo-controlled trial of Pleconaril for the treatment of neonates with enterovirus sepsis. J Pediatr Inf Disease : 1-10, 2015. DOI : 1093//jpids/piv015
 
58) Wang D, Chen Y, Jiang J et al : Carvedilol has stronger anti-inflammation and anti-virus effects than metoprolol in murine model with coxsackievirus B3-induced viral myocarditis. Gene 547 : 195-201, 2014.
PubMed
59) English RF, Janosky JE, Ettedgui JA et al : Outcomes for children with acute myocarditis. Cardiol Young 14 : 488-493, 2004.
PubMed
P.268 掲載の参考文献
1) Nakagomi T, Nakagomi O, Takahashi Y et al : Incidence and burden of rotavirus gastroenteritis in Japan, as estimated from a prospective sentinel hospital study. J Infect Dis 192 (Suppl 1) : S106-110, 2005.
PubMed
2) Tate JE, Burton AH, Boschi-Pinto C et al : 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes : a systematic review and meta-analysis. Lancet Infect Dis 12 (2) : 136-141, 2012.
PubMed
3) 津川毅, 堤裕幸 : ロタウイルス感染症の現状と課題. 小児内科 45 : 638-641, 2013.
 
4) Konno T, Suzuki H, Kutsuzawa T et al : Human rotavirus infection in infants and young children with intussusception. J Med Virol 2 (3) : 265-269, 1978.
PubMed
5) Rotbart HA, Nelson WL, Glode MP et al : Neonatal rotavirus-associated necrotizing enterocolitis : case control study and prospective surveillance during an outbreak. J Pediatr 112 (1) : 87-93, 1988.
PubMed
6) Kawamura Y, Miura H, Mori Y et al : Three infants with rotavirus gastroenteritis complicated by severe gastrointestinal bleeding. J Med Virol 88 (1) : 171-174, 2016.
PubMed
7) Keidan I, Shif I, Keren G et al : Rotavirus encephalopathy : evidence of central nervous system involvement during rotavirus infection. Pediatr Infect Dis J 11 (9) : 773-775, 1992.
PubMed
8) Yoshida A, Kawamitu T, Tanaka R et al : Rotavirus encephalitis : detection of the virus genomic RNA in the cerebrospinal fluid of a child. Pediatr Infect Dis J 14 (10) : 914-916, 1995.
PubMed
9) Dickey M, Jamison L, Michaud L et al : Rotavirus meningoencephalitis in a previously healthy child and a review of the literature. Pediatr Infect Dis J 28 (4) : 318-321. 2009.
 
10) Takahashi S1, Oki J, Miyamoto A et al : Encephalopathy associated with haemophagocytic lymphohistiocytosis following rotavirus infection. Eur J Pediatr 158 (2) : 133-137, 1999.
 
11) Grech V, Calvagna V, Falzon A et al : Fatal, rotavirus-associated myocarditis and pneumonitis in a 2-year-old boy. Ann Trop Paediatr 21 (2) : 147-148, 2001.
 
12) Yokoyama T, Sugimoto N, Kato E et al : Rotavirus gastroenteritis-associated urinary ammonium acid urate crystals. Pediatr Int 57 (1) : 158-160, 2015.
PubMed
13) Ashida A, Fujieda M, Ohta K et al : Clinical characteristics of obstructive uropathy associated with rotavirus gastroenteritis in Japan. Clin Nephrol 77 (1) : 49-54, 2012.
PubMed
14) Yolken R, Murphy M : Sudden infant death syndrome associated with rotavirus infection. J Med Virol 10 (4) : 291-296, 1982.
PubMed
15) Fischer TK, Ashley D, Kerin T et al : Rotavirus antigenemia in patients with acute gastroenteritis. J Infect Dis 192 (5) : 913-919, 2005.
PubMed
16) Sugata K, Taniguchi K, Yui A et al : Analysis of rotavirus antigenemia and extraintestinal manifestations in children with rotavirus gastroenteritis. Pediatrics 122 (2) : 392-397, 2008.
PubMed
17) Sugata K, Taniguchi K, Yui A et al : Analysis of rotavirus antigenemia in hematopoietic stem cell transplant recipients. Transpl Infect Dis 14 (1) : 49-56, 2012.
PubMed
18) Blutt SE, Kirkwood CD, Parreno V et al : Rotavirus antigenaemia and viraemia : a common event? Lancet 362 (9394) : 1445-1449, 2003.
PubMed
19) Blutt SE, Conner ME : Rotavirus : to the gut and beyond! Curr Opin Gastroenterol 23 (1) : 39-43, 2007.
 
20) Nakano I, Taniguchi K, Ishibashi-Ueda H et al : Sudden death from systemic rotavirus infection and detection of nonstructural rotavirus proteins. J Clin Microbiol 49 (12) : 4382-4385, 2011.
PubMed
21) Hoshino A, Saitoh M, Oka A et al : Epidemiology of acute encephalopathy in Japan, with emphasis on the association of viruses and syndromes. Brain Dev 34 (5) : 337-343, 2012.
PubMed
22) Kawamura Y, Ohashi M, Ihira M et al : Nationwide survey of rotavirus-associated encephalopathy and sudden unexpected death in Japan. Brain Dev 36 (7) : 601-607, 2014.
PubMed
23) Mizuguchi M, Yamanouchi H, Ichiyama T et al : Acute encephalopathy associated with influenza and other viral infections. Acta Neurol Scand Suppl 186 : 45-56, 2007.
PubMed
24) Yoshikawa T, Ohashi M, Miyake F et al : Exanthem subitum-associated encephalitis : nationwide survey in Japan. Pediatr Neurol 41 (5) : 353-358, 2009.
PubMed
25) Dickey M, Jamison L, Michaud L et al : Rotavirus meningoencephalitis in a previously healthy child and a review of the literature. Pediatr Infect Dis J 28 (4) : 318-321, 2009.
 
26) Kirton A, Busche K, Ross C et al : Acute necrotizing encephalopathy in caucasian children : two cases and review of the literature. J Child Neurol 20 (6) : 527-532, 2005.
PubMed
27) Makino M, Tanabe Y, Shinozaki K et al : Haemorrhagic shock and encephalopathy associated with rotavirus infection. Acta Paediatr 85 (5) : 632-634, 1996.
PubMed
28) Holmberg L : Haemorrhagic shock and encephalopathy syndrome. Acta Paediatr 85 (5) : 535-536, 1996.
PubMed
29) Salmi TT, Arstila P, Koivikko A : Central nervous system involvement in patients with rotavirus gastroenteritis. Scand J Infect Dis 10 (1) : 29-31, 1978.
PubMed
30) Takanashi J : Two newly proposed infectious encephalitis/encephalopathy syndromes. Brain Dev 31 (7) : 521-528, 2009.
PubMed
31) Kawamura Y, Ohashi M, Ihira M et al : Nationwide survey of rotavirus-associated encephalopathy and sudden unexpected death in Japan. Brain Dev 36 (7) : 601-607, 2014.
PubMed
32) Kato Z, Orii KE, Morimoto M et al : A transient lesion in the corpus callosum during rotavirus infection. Pediatr Neurol 41 (6) : 467-469, 2009.
 
33) Fukuda S, Kishi K, Yasuda Ket al : Rotavirus-associated encephalopathy with a reversible splenial lesion. Pediatr Neurol 40 (2) : 131-133, 2009.
 
34) Nishimura S, Ushijima H, Nishimura S et al : Detection of rotavirus in cerebrospinal fluid and blood of patients with convulsions and gastroenteritis by means of the reverse transcription polymerase chain reaction. Brain 15 (6) : 457-459, 1993.
PubMed
35) Yoshida A, Kawamitu T, Tanaka R et al : Rotavirus encephalitis : detection of the virus genomic RNA in the cerebrospinal fluid of a child. Pediatr Infect Dis J 14 (10) : 914-916, 1995.
PubMed
36) Hongou K, Konishi T, Yagi S et al : Rotavirus encephalitis mimicking afebrile benign convulsions in infants. Pediatr Neurol 18 (4) : 354-357, 1998.
PubMed
37) Wong CJ, Price Z, Bruckner DA : Aseptic meningitis in an infant with rotavirus gastroenteritis. Pediatr Infect Dis 3 (3) : 244-246, 1984.
 
38) Keidan I, Shif I, Keren G et al : Rotavirus encephalopathy : evidence of central nervous system involvement during rotavirus infection. Pediatr Infect Dis J 11 (9) : 773-775, 1992.
PubMed
39) Lynch M, Lee B, Azimi P et al : Rotavirus and central nervous system symptoms : cause or contaminant? Case reports and review. Clin Infect Dis 33 (7) : 932-938, 2001.
PubMed
40) Kensei G, Naoko N, Shinji K et al : Pathophysiological analysis of five severe cases with rotavirus infection. JMM Case Reports, in press, 2015.
 
41) Nagao T, Morishima T, Kimura H et al : Prognostic factors in influenza-associated encephalopathy. Pediatr Infect Dis J 27 (5) : 384-389, 2008.
PubMed
42) Kawamura Y, Sugata K, Ihira M et al : Different characteristics of human herpesvirus 6 encephalitis between primary infection and viral reactivation. J Clin Virol 51 (1) : 12-19, 2011.
PubMed
43) Aiba H, Mochizuki M, Kimura M et al : Predictive value of serum interleukin-6 level in influenza virus-associated encephalopathy. Neurology 57 (2) : 295-299, 2001.
PubMed
44) Komori H, Wada M, Eto M et al : Benign convulsions with mild gastroenteritis : a report of 10 recent cases detailing clinical varieties. Brain 17 (5) : 334-337, 1995.
PubMed
45) Kawano G, Oshige K, Syutou S et al : Benign infantile convulsions associated with mild gastroenteritis : a retrospective study of 39 cases including virological tests and efficacy of anticonvulsants. Brain Dev 29 (10) : 617-622, 2007.
PubMed
46) Narchi H : Benign afebrile cluster convulsions with gastroenteritis : an observational study. BMC Pediatr 4 : 2, 2004.
PubMed
47) Caraballo RH, Ganez L, Santos Cde L et al : Benign infantile seizures with mild gastroenteritis : study of 22 patients. Seizure 18 (10) : 686-689, 2009.
PubMed
48) Verrotti A, Nanni G, Agostinelli S et al : Benign convulsions associated with mild gastroenteritis : a multicenter clinical study. Epilepsy Res 93 (2-3) : 107-114, 2011.
PubMed
49) Motoyama M, Ichiyama T, Matsushige T et al : Clinical characteristics of benign convulsions with rotavirus gastroenteritis. J Child Neurol 24 (5) : 557-561, 2009.
PubMed
50) Matsufuji H, Ichiyama T, Isumi H et al : Low-dose carbamazepine therapy for benign infantile convulsions. Brain Dev 27 (8) : 554-557, 2005.
PubMed
51) Okumura A, Uemura N, Negoro T et al : Efficacy of antiepileptic drugs in patients with benign convulsions with mild gastroenteritis. Brain Dev 26 (3) : 164-167, 2004.
PubMed
52) Okumura A, Tanabe T, Kato T et al : A pilot study on lidocaine tape therapy for convulsions with mild gastroenteritis. Brain Dev 26 (8) : 525-529, 2004.
 
53) Uemura N, Okumura A, Negoro T et al : Clinical features of benign convulsions with mild gastroenteritis. Brain Dev 24 (8) : 745-749, 2002.
PubMed
54) Yeom JS, Kim YS, Seo JH et al : Distinctive pattern of white matter injury in neonates with rotavirus infection. Neurology 84 (1) : 21-27, 2015.
PubMed
55) Verboon-Maciolek MA, Truttmann AC, Groenendaal F et al : Development of cystic periventricular leukomalacia in newborn infants after rotavirus infection. J Pediatr 160 (1) : 165-168, 2012.
PubMed
56) Lee KY, Oh KW, Weon YC et al : Neonatal seizures accompanied by diffuse cerebral white matter lesions on diffusion-weighted imaging are associated with rotavirus infection. Eur J Paediatr Neurol 18 (5) : 624-631, 2014.
PubMed
57) Verboon-Maciolek MA, Utrecht FG, Cowan F et al : White matter damage in neonatal enterovirus meningoencephalitis. Neurology 66 (8) : 1267-1269, 2006.
 
58) Verboon-Maciolek MA, Groenendaal F, Hahn CD et al : Human parechovirus causes encephalitis with white matter injury in neonates. Ann Neurol 64 (3) : 266-273, 2008.
PubMed
59) Belcastro V, Bini P, Barachetti R et al : Teaching neuroimages : neonatal parechovirus encephalitis : typical MRI findings. Neurology 82 (3) : e23, 2014.
PubMed
60) Vesikari T : Rotavirus vaccination : a concise review. Clin Microbiol Infect 18 (Suppl 5) : 57-63, 2012.
 
61) Phua KB, Lim FS, Lau YL et al : Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants : randomised, double-blind, controlled study. Vaccine 27 (43) : 5936-5941, 2009.
PubMed
P.276 掲載の参考文献
1) Meissner HC and Hall CB : Chapter 181 Respiratory Syncytial Virus. Feigin and Cherry's Textbook of PEDIATRIC INFECTIOUS DDISEASE Seventh Edition, pp. 2407-2434, ELESEVIER SAUNDERS, Philadelphia, 2014.
 
2) Schuster JE and Williams JV : Chapter 182 Human Metapneumovirus. Feigin and Cherry's Textbook of PEDIATRIC INFECTIOUS DDISEASE Seventh Edition, pp. 2407-2434, ELESEVIER SAUNDERS, Philadelphia, 2014.
 
3) Weiss RA and McMichael AJ : Social and environmental risk factors in the emergence of infectious diseases, Nature Medicine 10, S70-S76, 2004.
PubMed
4) Thompson WW, Shay DK, Weintraub E et al : Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289 : 179-186, 2003.
PubMed
5) Willson DF, Landrigan CP, Horn SD et al : Complications in infants hospitalized for bronchiolitis or respiratory syncytial virus pneumonia. J Pediatr 143 : S142-149, 2003.
PubMed
6) American Academy of Pediatrics Subcommittee on Diagnosis and Management of Bronchiolitis : Diagnosis and management of bronchiolitis. Pediatrics 118 : 1774-1793. 2006.
 
7) Hall CB, Douglas RG Jr, Geiman JM : Possible transmission by fomites of respiratory syncytial virus. J Infect Dis 141 : 98-102, 1980.
PubMed
8) 青木知信 : 1. パリビズマブの基本データ, II. パリビズマブを知る. 楠田聡監, RSV感染症×パリビズマブDATA BOOK, pp. 24-31, メディカルビュー社, 東京, 2014.
 
9) Cox RA, Rao P, Brandon-Cox C : The use of palivizumab monoclonal antibody to control an outbreak of respiratory syncytial virus infection in a special care baby unit. J Hosp Infect 48 : 186-192. 2001.
 
10) American Academy of Pediatrics Committee on Infectious Diseases, and American Academy of Pediatrics Bronchiolitis Guidelines Committee : Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. Pediatrics 134 : 415-420. 2014.
 
11) Hart RJ. An outbreak of respiratory syncytial virus infection in an old people's home. J Infect 8 : 259-261, 1984.
 
12) Sorvillo FJ, Huie SF, Strassburg MA et al : An outbreak of respiratory syncytial virus pneumonia in a nursing home for the elderly. J Infect 9 : 252-256, 1984.
 
13) Vikerfors T, Grandien M, Olcen P : Respiratory syncytial virus infections in adults. Am Rev Respir Dis 136 : 561-564, 1987.
PubMed
14) Falsey AR, Hennessey PA, Formica MA et al : Respiratory Syncytial Virus Infection in Elderly and High-Risk Adults. N Engl J Med 352 : 1749-1759, 2005.
PubMed
P.282 掲載の参考文献
1) Pantell RH, Newman TB, Bernzweig J et al : Management and outcomes of care of fever in early infancy. JAMA 291 (10) : 1203-1212, 2004.
PubMed
2) Jaskiewicz JA, McCarthy CA, Richardson AC et al : Febrile infants at low risk for serious bacterial infection--an appraisal of the Rochester criteria and implications for management. Febrile Infant Collaborative Study Group. Pediatrics 94 (3) : 390-396, 1994.
 
3) Baker MD, Bell LM, Avner JR : Outpatient management without antibiotics of fever in selected infants. N Engl J Med 329 (20) : 1437-1441, 1993.
PubMed
4) Baskin MN, O'Rourke EJ, Fleisher GR : Outpatient treatment of febrile infants 28 to 89 days of age with intramuscular administration of ceftriaxone. J Pediatr 120 (1) : 22-27, 1992.
 
5) 糸永知代, 奥井秀由起, 國崎純他 :日本小児感染症学会若手会員研修会第4回安曇野セミナー, 乳児期早期発熱にどう対処するか? -安曇野クライテリアの提案-. 小児感染免疫 24 : 499-505, 2012.
 
6) McCarthy PL, Lembo RM, Baron MA et al : Observation scales to identify serious illness in febrile children. Pediatrics 70 (5) : 802-809, 1982.
 
7) Ito M, Yamashita T, Tsuzuki H et al : Isolation and identification of a novel human parechovirus. J Gen Virol 85 : 391-398, 2004.
PubMed
8) 横田俊平, 譲原佐栄子, 田中文子他 : 新生児期に高熱を生じる新興感染症ヒト・パレコウイルスの病態 横浜市でみられた小流行からの考察. 日小児会誌 116 : 679-686, 2012.
 
9) Aizawa Y, Yamanaka T, Watanabe K et al : Asymptomatic children might transmit human parechovirus type 3 to neonates and young infants. J Clin Virol 70 : 105-108, 2015.
 
10) 長村敏生, 市川光太郎 : 公費助成によるインフルエンザ菌b型, 肺炎球菌ワクチン接種が小児細菌性髄膜炎および菌血症の発生に及ぼす影響. 日本臨床救急医学会雑誌 17 (4) : 551-557, 2014.
Medical*Online

【臨床報告】

P.291 掲載の参考文献
1) 矢吹省司, 牛田享弘, 竹下克志他 :日本における慢性疼痛保有者の実態調査. 臨床整形外科 47 (2) : 127-134, 2012.
 
2) 山下哲, 成田年 : 慢性痛と睡眠障害. Anesthesia 21 Century 15 (2) : 67-71, 2013.
 
3) 仙波恵美子 : ストレスにより痛みが増強する脳メカニズム. 日本緩和医療薬学雑誌 3 : 73-84, 2010.
 
4) 寺澤捷年 : 症例から学ぶ. 和漢診療学, pp. 32, 40, 医学書院, 東京, 1990.
 
5) 光畑裕正 : 神経障害性疼痛に対する漢方治療. ペインクリニック 32 (12) : 1825-1834, 2011.
Medical*Online
6) 光畑裕正 : 外傷性神経障害性疼痛に抑肝散の効果が認められた症例. 漢方と診療 6 (2) : 137-137, 2015.
 
7) 五十嵐康 : 抑肝散の作用メカニズムの解明. Geriatric Medicine 46 (3) 255-261, 2008.
Medical*Online
8) 大塚敬節, 矢数道明, 清水藤太郎 : 漢方診療医典 pp. 425-426, 南山堂, 東京, 1979.
 

【Diagnosis】

P.299 掲載の参考文献
1) Widdershoven J, van Munster P, De Abreu R et al : Four methods compared for measuring des carboxy-prothrombin (PIVKA-II). Clin Chem 33 (11) : 2074-2078, 1987.
PubMed
2) Wang C-S, Lin C-L, Lee H-C et al : Usefulness of serum des-γ-carboxy prothrombin in detection of hepatocellular carcinoma. World J Gastroenterol 11 (39) : 6115-6119, 2005.
 
3) Kobayashi M, Ikeda K, Kawamura Y et al : High serum des-gamma-carboxy prothrombin level predicts poor prognosis after radiofrequency ablation of hepatocellular carcinoma. Cancer 115 (3) : 571-580, 2009.
PubMed
4) Park H, Park JY : Clinical significance of AFP and PIVKA II responses for monitoring treatment outcomes and predicting prognosis in patients with hepatocellular carcinoma. BioMed Research International 2013 : 1-6, 2013.
 
5) Volk ML, Hernandez JC, Su GL et al : Risk factors for hepatocellular carcinoma may impair the performance of biomarkers : A comparison of AFP, DCP, and AFP-L3. Cancer Biomarkers 3 (2) : 79-87, 2007.
PubMed
6) Block TM, Marrero J, Gish RG et al : The degree of readiness of selected biomarkers for the early detection of hepatocellular carcinoma : Notes from a recent workshop. Cancer Biomarkers 4 (1) : 19-33, 2008.
 
7) Yoon YJ, Han KH, Kim do Y : Role of serum prothrombin induced by vitamin K absence or antagonist-II in the early detection of hepatocellular carcinoma in patients with chronic hepatitis B virus infection. Scand J Gastroenterol 44 : 861-866, 2009.
PubMed
8) 科学的根拠に基づく肝癌診療ガイドライン2013年度版. pp. 41-45, 金原出版, 東京, 2013.
 
9) Kinukawa H, Shirakawa T, Yoshimura T. Epitope characterization of an anti-PIVKA-II antibody and evaluation of a fully automated chemiluminescent immunoassay for PIVKA-II. Clin Biochem. 48 : 1120-1125, 2015.
PubMed
P.309 掲載の参考文献
1) van den Hoogen BG, de Jong JC, Groen J et al : A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 7 (6) : 719-724, 2001.
 
2) 菊田英明 : ヒト・メタニューモウイルス. ウイルス 56 (2) : 171-182, 2006.
 
3) van den Hoogen BG, Herfst S, Sprong L et al : Antigenic and genetic variability of human metapneumoviruses. Emerg Infect Dis 10 (4) : 658-666, 2004.
PubMed
4) Huck B, Scharf G, Neumann-Haefelin D et al : Novel human metapneumovirus sublineage. Emerg Infect Dis 12 (1) : 147-150, 2006.
PubMed
5) Williams JV, Harris PA, Tollefson SJ et al : Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N Engl J Med 350 (5) : 443-450, 2004.
PubMed
6) Ulloa-Gutierrez R, Skippen P, Synnes A et al : Life-threatening human metapneumovirus pneumonia requiring extracorporeal membrane oxygenation in a preterm infant. Pediatrics 114 (4) : e517-e519, 2004.
 
7) Foulongne V, Lechiche C, Reynes J et al : Human metapneumovirus pneumonia in an adult patient hospitalized for suspected severe acute respiratory syndrome (SARS). Presse Med 33 (15) : 1006-1007, 2004.
 
8) Boivin G, De Serres G, Hamelin M-E et al : An outbreak of severe respiratory tract infection due to human metapneumovirus in a long-term care facility. Clin Infect Dis 44 (9) : 1152-1158, 2007.
 
9) Abiko C, Mizuta K, Itagaki T et al : Outbreak of human metapneumovirus detected by use of the Vero E6 cell line in isolates collected in Yamagata, Japan, in 2004 and 2005. J Clin Microbiol 45 (6) : 1912-1919, 2005.
PubMed
10) 白石博昭, 豊村研吾, 平泰子他 : 高齢者福祉施設におけるヒトメタニューモウイルス集団感染事例-福岡県. IASR 27 : 178-179, 2006.
 
11) 横井一, 水村綾乃, 小林圭子他 : 福祉施設におけるヒトメタニューモウイルス集団感染事例-千葉市. IASR 34 : 234-235, 2013.
 
12) Kaida A, Iritani N, Kubo H et al : Seasonal distribution and phylogenetic analysis of human metapneumovirus among children in Osaka City, Japan. J Clin Virol 35 (4) : 394-399, 2006.
PubMed
13) Kikuta H, Sakata C, Gamo R et al : Comparison of a Lateral-Flow Immunochromatography Assay with Real-Time Reverse Transcription-PCR for Detection of Human Metapneumovirus. J Clin Microbiol 46 (3) : 928-932, 2008.
PubMed
14) Montes M, Vicente D, Esnal O, Cilla G, Pe E, Donostia H : A PCR-restriction fragment length polymorphism assay to genotype human metapneumovirus. Eur Soc Clin Microbiol Infect Dis 14 (1) : 82-96, 2007.
 
15) Ebihara T, Endo R, Kikuta H et al : Human metapneumovirus infection in Japanese children. J Clin Microbiol 42 (1) : 126-132, 2004.
 
16) 菊田英明 : 迅速ヒトメタニューモウイルス診断キット-保険適用されたイムノクロマト法によるhMPV抗原定性-. モダンメディア 60 (5) : 169-173, 2014.
 
17) Kim JK, Jeon JS, Kim JW et al : Epidemiology of respiratory viral infection using multiplex RT-PCR in Cheonan, Korea (2006-2010). J Microbiol Biotechnol 23 (2) : 267-273, 2013.
PubMed
18) 高尾信一, 原三千丸, 島津幸枝他 : 小児の急性呼吸器感染症に関与するヒト・メタニューモウイルスの実態について. 広島県獣医学会雑誌 24 : 87-92, 2009.
 
19) Camps M, Ricart S, Dimova V et al : Prevalence of human metapneumovirus among hospitalized children younger than 1 year in Catalonia, Spain. J Med Virol 80 (8) : 1452-1460, 2008.
 
20) 吉岡政純, 石川和弘, 池田雄史他 : 小児における呼吸器感染症から検出されたヒトメタニューモウイルスに関する分子疫学および臨床医学的検討. 感染症学雑誌 86 (6) : 755-762, 2012.
 
21) 高尾信一, 下薗広行, 柏弘他 : 本邦において初めて流行が確認された小児のhuman metapneumovirus感染症の臨床的, 疫学的解析. 感染症学雑誌 78 (2) : 129-137, 2004.
 
22) Agapov E, Sumino KC, Gaudreault-Keener M et al : Genetic variability of human metapneumovirus infection : evidence of a shift in viral genotype without a change in illness. J Infect Dis 193 (3) : 396-403, 2006.
PubMed
P.320 掲載の参考文献
1) 家森幸男 :日本臨床 37 : 64, 1979.
 
2) Laragh JH, Letcher RL, Pickering TG et al : Renin profiling for diagnosis and treatment of hypertension. JAMA 241 : 151-156, 1979.
PubMed
3) Buhler FR : Age and cardiovascular response adaptation. Determinants of an antihypertensive treatment concept primarily based on beta-blockers and calcium entry blockers. Hypertension 5 : III94, 1983.
PubMed
4) 高橋伯夫 : 29. 高血圧性疾患. 診療群別臨床検査のガイドライン 2003, 日本臨床検査医学会, p. 122, 2003.
 
5) McMurray JJ, Pitt B, Latini R et al : Effects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failure. Circ Heart Fail 1 : 17-24, 2008.
 
6) Vaughan ED Jr, Laragh JH, Gavras I et al : Symposium on high blood pressure : volume factor in low and renin essential hypertension : treatment with either spironolactone or chlorthalidone. Am J Cardiol 32 : 523, 1973.
PubMed
7) 萩原俊男, 飯沼一茂, 岩永圭市他 : ダイナボットレニンリアキットII の基礎的検討ならびに臨床応用. 医学と薬学 5 : 589-594, 1981.
 
P.333 掲載の参考文献
1) 岩原由樹, 久保田俊郎 : エストロゲン (エストラジオール, 尿中エストリオール) プロゲステロン. medica 52 (増刊号) : 38-383, 2015.
 
2) 東口篤司 : ARTにおける黄体補充療法. 産科と婦人科 7 (49) : 459-764, 2015.
 
3) 北脇城 : 黄体ホルモン製剤の種類と特性. 産科と婦人科 7 (49) : 733-738, 2015.
 
4) Coucke W, Devleeschouwer N, Libeer JC et al : Accuracy and reproducibility of automated estradiol-17b and progesterone assays using native serum samples : results obtained in the Belgian external assessment scheme. Hum Reprod 22 (12) : 3204-3209, 2007.
 
5) 松崎利也, 木内理世, 仁木博文他 : 血中性腺系ホルモン測定値の互換性に関する検討. ホルモンと臨床 60 (10) : 849-859, 2012.
 
6) 坂倉啓一, 高加国夫, 渡辺正一他 : 全自動電気化学発光免疫測定装置「モジュラーアナリティクス <EE>」を用いた性腺ホルモンの基礎的検討ならびに下垂体, 性腺ホルモンの基準範囲の検討. ホルモンと臨床 52 (9) : 929-943, 2004.
 
7) 坂倉啓一, 高加国夫 : 全自動電気化学発光免疫測定装置「モジュラーアナリティクス <EE>」を用いた閉経女性の下垂体, 性腺ホルモンの基準範囲の検討-第二法-. ホルモンと臨床 53 (5) : 123-129, 2005.
 
8) 日本産婦人科学会,日本産婦人科医会 : 産婦人科診療ガイドライン-産科編 2014, p. XI.
 
9) Jordan J et al : Luteal phase defect : the sensitivity and specificity of diagnostic methods in common clinical use. Fertil Steril 62 : 54-62, 1994.
PubMed
10) 杉岡美智代, 吉岡尚美, 疇津美佳他 : 生殖補助医療における「全自動化学発光 免疫測定装置エクルーシス 2010」を用いた血清ホルモン値の基準値検討. 医学と薬学 56 (3) : 419-429, 2006.
Medical*Online
11) 藤本晃久, 藤原敏博, 矢野哲他 : IVFにおける標準的排卵誘発. 産婦人科の実際 55 (6) : 897-900, 2006.
 
12) Smitz J, Erard P, Camus M et al : Pituitary gonadotrophin secretory capacity during the luteal phase in superovulation using GnRH-agonists and HMG in a desensitization or flare-up protocol. Human Reprod 7 (9) : 1225-1229, 1997.
 
13) Beckers NGM, Laven JSE, Ejikemans MJC et al : Follicular and luteal phase characteristics following early cessation of gonadotrophin-releasing hormone agonist during ovarian stimulation for in-vitro fertilization. Hum Reprod 15 (1) : 43-49, 2000.
 
14) Macklon NS, Fauser BC : Impact of ovarian hyperstimulatrion on the luteal phase. J Reprod Fertil Suppl 55 : 101-108, 2000.
PubMed
P.338 掲載の参考文献
1) 乾正幸, 乾純和, 大和田進他 : H. pylori (HP) IgG抗体測定キットの特性. 胃がんリスク検診 (ABC検診) マニュアル, 改訂2版, 認定NPO法人日本胃がん予知・診断・治療研究機構編, pp. 39-42, 南山堂, 東京, 2014.
 
2) 三木一正 : ABC分類による胃がんリスクの層別化. 胃がんリスク検診 (ABC検診) マニュアル, 訂2版, 認定NPO法人日本胃がん予知・診断・治療研究機構編, pp. 18-20, 南山堂, 東京, 2014.
 
3) 春間賢監 : 胃炎の京都分類. 日本メディカルセンター, 東京, 2014.
 
4) 菊地正悟 : 「血清抗H. pylori IgG抗体検査」の陽性・陰性判定に関する日本ヘリコバクター学会からの注意喚起 (平成26年12月25日) に至った背景と経過. 日本ヘリコバクター学会誌 17 : 21-24, 2015.
Medical*Online
5) 乾正幸, 大和田進, 乾純和他 : 血清ABC分類における血清A群のピロリ菌感染状態の解析と診断精度向上にむけて. 日本ヘリコバクター学会誌 17 (2) : 67-73, 2016.
 

書評

最近チェックした商品履歴

Loading...